Company: BWAY
Filing Date: 2025-04-22
Form Type: F-3
Source: 0001171843-25-002378
Chunk: 16

Company: Brainsway Ltd.
Filing Date: 2025-04-22
Form: F-3
Chunk 16
---
itors; |

| ● | appointment of external directors (if applicable); |

| ● | approval of certain related party transactions; |

| ● | increases or reductions of our authorized share capital; |

| ● | mergers; and |

| ● | the exercise of our board of director’s powers by a general meeting, if our board of directors is unable to exercise its powers and the exercise of any of its powers is required for our proper management. |

| 8 |

The Company shall give notice of a general meeting
only to the shareholders registered in the registry, whose address is in Israel. Our articles of association, in accordance with the provisions
of the Israeli Companies Law requires that a notice of any annual general meeting or special general meeting be published at least 14 days
prior to the meeting and if the agenda of the meeting includes the appointment or removal of directors, the approval of transactions with
office holders or interested or related parties, or an approval of a merger, or as otherwise required under applicable law, notice must
be published at least 35 days prior to the meeting. Under the Israeli Companies Law, shareholders of a public company are not permitted
to take action by written consent in lieu of a meeting.

Election of Directors. Our Ordinary Shares do
not have cumulative voting rights for the election of directors. As a result, the holders of a majority of the voting power represented
at a shareholders meeting have the power to elect all of our directors. Under our articles of association, our board of directors must
consist of not less than four (4) but no more than eight (8) directors, including the designee(s) of the selling shareholder
(who has the right to designate (i) one nominee to the board of directors so long as the selling shareholder holds, directly or indirectly,
together with its affiliates, 10% of our issued and outstanding share capital or (ii) two nominees to the board of directors so long as
the selling shareholder holds, directly or indirectly, together with its affiliates, 20% of our issued and outstanding share capital),
but not including any external directors required to be appointed by the Israel Companies Law and not including up to two (2) additional
directors which may be appointed by our board of directors whose term of office would expire on the next following annual meeting of shareholders
after their appointment, provided that they may be reappointed by the board of directors for one additional term of
office, provided that they may be reappointed at the annual meeting